\-\ Texto\\:\\ \ \(0\)\
\-\ figure\\ 1\\.\\ patient\\ a\\.\\ tc\\-99m\\ hmpao\\ tagged\\ wbc\\ study\\ demonstrates\\ normal\\ biodistribution\\ of\\ the\\ radiopharmaceutical\\ as\\ well\\ as\\ a\\ focal\\ region\\ of\\ linear\\ uptake\\ in\\ the\\ right\\ lower\\ quadrant\\ of\\ the\\ abdomen\\.\ \(0\)\
\-\ figure\\ 2\\.\\ patient\\ a\\.\\ contrast\\ enhanced\\ ct\\ through\\ the\\ pelvis\\ demonstrates\\ a\\ loop\\ of\\ small\\ bowel\\ with\\ wall\\ thickening\\ abutting\\ the\\ right\\ pelvic\\ sidewall\\.\\ \ \(0\)\
\-\ figure\\ 3\\.\\ patient\\ b\\.\\ f\\-18\\ fdg\\ pet\\ axial\\ image\\ through\\ pelvis\\ demonstrates\\ focal\\ linear\\ fdg\\ avidity\\.\ \(0\)\
\-\ figure\\ 4\\.\\ patient\\ b\\.\\ non\\-contrast\\ ct\\ of\\ pelvis\\ demonstrates\\ a\\ loop\\ of\\ small\\ bowel\\ with\\ wall\\ thickening\\.\\ there\\ is\\ mild\\ surrounding\\ mesenteric\\ edema\\ as\\ well\\ as\\ prominence\\ of\\ the\\ surrounding\\ fat\\.\\ \ \(0\)\
\-\ figure\\ 5\\.\\ patient\\ b\\.\\ pet\\ image\\ fused\\ with\\ the\\ ct\\ image\\ \\(studies\\ were\\ obtained\\ simultaneously\\)\\.\\ correlation\\ of\\ fdg\\ avidity\\ to\\ thickened\\ small\\ bowel\\ loop\\.\ \(0\)\
\-\ figure\\ 6\\.\\ patient\\ a\\.\\ selected\\ image\\ from\\ a\\ small\\ bowel\\ follow\\-through\\ concentrating\\ on\\ the\\ right\\ lower\\ quadrant\\.\\ demonstration\\ of\\ narrowing\\ of\\ the\\ terminal\\ ileum\\ \\(a\\ \\‚\\Ä\\ústring\\‚\\Ä\\ù\\ sign\\)\\,\\ surrounding\\ mass\\ effect\\ and\\ effacement\\ of\\ the\\ cecum\\.\\ study\\ was\\ obtained\\ several\\ months\\ after\\ the\\ previously\\ shown\\ tc\\-99m\\ hmpao\\/wbc\\ study\\.\ \(0\)\
\-\ crohn\\'s\\ disease\\ on\\ pet\\ and\\ tc\\-99m\\ hmpao\\ tagged\\ wbc\\ scanning\ \(0\)\
\-\ crohn\\'s\\ disease\\ \\(known\\ diagnosis\\)\ \(0\)\
\-\ two\\ patients\\ with\\ the\\ same\\ diagnosis\\,\\ the\\ request\\ for\\ the\\ studies\\ read\\ \\"assess\\ disease\\ status\\"\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ figure\\:\\ 0\\.1239601858735571\ \(0\)\
\-\ fdg\\:\\ 0\\.07217431020707814\ \(0\)\
\-\ avidity\\:\\ 0\\.07032356054897448\ \(0\)\
\-\ b\\.\\:\\ 0\\.06594608838549519\ \(0\)\
\-\ loop\\:\\ 0\\.06476463672048575\ \(0\)\
\-\ hmpao\\:\\ 0\\.06432228625841219\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.0634245817044438\ \(0\)\
\-\ a\\.\\:\\ 0\\.0622099575744331\ \(0\)\
\-\ pet\\:\\ 0\\.05824396212571646\ \(0\)\
\-\ tagged\\:\\ 0\\.052878512752071755\ \(0\)\
\-\ bowel\\:\\ 0\\.046406121781554274\ \(0\)\
\-\ image\\:\\ 0\\.04621972582333508\ \(0\)\
\-\ pelvis\\:\\ 0\\.040325862423267904\ \(0\)\
\-\ crohn\\:\\ 0\\.03954132625036484\ \(0\)\
\-\ sidewall\\:\\ 0\\.03816241741976839\ \(0\)\
\-\ hmpao\\/wbc\\:\\ 0\\.03816241741976839\ \(0\)\
\-\ study\\:\\ 0\\.03651469294623324\ \(0\)\
\-\ surrounding\\:\\ 0\\.03648266577097098\ \(0\)\
\-\ small\\:\\ 0\\.034087883712227166\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03232244505027162\ \(0\)\
\-\ biodistribution\\:\\ 0\\.03216114312920609\ \(0\)\
\-\ linear\\:\\ 0\\.031364169463863965\ \(0\)\
\-\ simultaneously\\:\\ 0\\.031195153729577478\ \(0\)\
\-\ concentrating\\:\\ 0\\.03040588292094564\ \(0\)\
\-\ f\\-18\\:\\ 0\\.02973856396065448\ \(0\)\
\-\ follow\\-through\\:\\ 0\\.02973856396065448\ \(0\)\
\-\ studies\\:\\ 0\\.027632042578174542\ \(0\)\
\-\ wbc\\:\\ 0\\.026970345026630406\ \(0\)\
\-\ obtained\\:\\ 0\\.026301871002111184\ \(0\)\
\-\ quadrant\\:\\ 0\\.026037886874338133\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.0258974245883562\ \(0\)\
\-\ request\\:\\ 0\\.0258974245883562\ \(0\)\
\-\ thickening\\:\\ 0\\.025079000603405642\ \(0\)\
\-\ string\\:\\ 0\\.024982666607112878\ \(0\)\
\-\ abutting\\:\\ 0\\.024781281258044078\ \(0\)\
\-\ demonstration\\:\\ 0\\.02389472535914359\ \(0\)\
\-\ read\\:\\ 0\\.02389472535914359\ \(0\)\
\-\ scanning\\:\\ 0\\.022649348422122892\ \(0\)\
\-\ selected\\:\\ 0\\.022415291187186635\ \(0\)\
\-\ as\\:\\ 0\\.02238229447435719\ \(0\)\
\-\ patient\\:\\ 0\\.022249141062763326\ \(0\)\
\-\ fused\\:\\ 0\\.022193242293734032\ \(0\)\
\-\ prominence\\:\\ 0\\.021880165836679375\ \(0\)\
\-\ wall\\:\\ 0\\.021429949092976158\ \(0\)\
\-\ terminal\\:\\ 0\\.02122725289410542\ \(0\)\
\-\ focal\\:\\ 0\\.021129814754445038\ \(0\)\
\-\ through\\:\\ 0\\.02101261487810276\ \(0\)\
\-\ cecum\\:\\ 0\\.020975006538590375\ \(0\)\
\-\ ileum\\:\\ 0\\.020736652524811033\ \(0\)\
\-\ correlation\\:\\ 0\\.020366426665771372\ \(0\)\
\-\ effacement\\:\\ 0\\.02029603480052557\ \(0\)\
\-\ assess\\:\\ 0\\.01854077459226512\ \(0\)\
\-\ disease\\:\\ 0\\.018139448587216937\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.018056829111797082\ \(0\)\
\-\ 6\\.\\:\\ 0\\.017974369393309226\ \(0\)\
\-\ mesenteric\\:\\ 0\\.01705766710288029\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01698891195480883\ \(0\)\
\-\ well\\:\\ 0\\.016736631627434207\ \(0\)\
\-\ lower\\:\\ 0\\.016639498436050757\ \(0\)\
\-\ thickened\\:\\ 0\\.016588362780338362\ \(0\)\
\-\ \\'s\\:\\ 0\\.016312091933913808\ \(0\)\
\-\ 5\\.\\:\\ 0\\.01595506367551266\ \(0\)\
\-\ enhanced\\:\\ 0\\.01582884469589597\ \(0\)\
\-\ previously\\:\\ 0\\.01554013744698397\ \(0\)\
\-\ ct\\:\\ 0\\.015523424070026532\ \(0\)\
\-\ same\\:\\ 0\\.015247677918796563\ \(0\)\
\-\ pelvic\\:\\ 0\\.015182903578204733\ \(0\)\
\-\ narrowing\\:\\ 0\\.01483310257207791\ \(0\)\
\-\ shown\\:\\ 0\\.01483310257207791\ \(0\)\
\-\ uptake\\:\\ 0\\.014696897942399187\ \(0\)\
\-\ 4\\.\\:\\ 0\\.01456484835671341\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.013816021289087271\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.013738577285837163\ \(0\)\
\-\ status\\:\\ 0\\.013204880178275556\ \(0\)\
\-\ effect\\:\\ 0\\.013097654775191536\ \(0\)\
\-\ factoid\\:\\ 0\\.012967253219108818\ \(0\)\
\-\ sign\\:\\ 0\\.012815785721922384\ \(0\)\
\-\ 3\\.\\:\\ 0\\.012657464121821331\ \(0\)\
\-\ several\\:\\ 0\\.011892176778018994\ \(0\)\
\-\ 2\\.\\:\\ 0\\.011763827453680771\ \(0\)\
\-\ right\\:\\ 0\\.011709502715719697\ \(0\)\
\-\ known\\:\\ 0\\.011705848850492726\ \(0\)\
\-\ 1\\.\\:\\ 0\\.01155493145583377\ \(0\)\
\-\ fat\\:\\ 0\\.011250702696457287\ \(0\)\
\-\ see\\:\\ 0\\.011039901347310772\ \(0\)\
\-\ abdomen\\:\\ 0\\.010958373432448902\ \(0\)\
\-\ two\\:\\ 0\\.01059450752214721\ \(0\)\
\-\ axial\\:\\ 0\\.010557538857436674\ \(0\)\
\-\ edema\\:\\ 0\\.010462872248620306\ \(0\)\
\-\ region\\:\\ 0\\.010448490161209146\ \(0\)\
\-\ months\\:\\ 0\\.01010364196835527\ \(0\)\
\-\ mild\\:\\ 0\\.009741356943424836\ \(0\)\
\-\ patients\\:\\ 0\\.00957391601457154\ \(0\)\
\-\ \\(\\:\\ 0\\.009381321120050138\ \(0\)\
\-\ \\)\\:\\ 0\\.009266723274198767\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009091493669401806\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00891666451074564\ \(0\)\
\-\ a\\:\\ 0\\.008584411294774918\ \(0\)\
\-\ were\\:\\ 0\\.00839950795103862\ \(0\)\
\-\ the\\:\\ 0\\.008378744527492472\ \(0\)\
\-\ contrast\\:\\ 0\\.008280414228605652\ \(0\)\
\-\ after\\:\\ 0\\.007653684859780097\ \(0\)\
\-\ on\\:\\ 0\\.006267454652514529\ \(0\)\
\-\ normal\\:\\ 0\\.0057991881151476235\ \(0\)\
\-\ of\\:\\ 0\\.0055478000379994485\ \(0\)\
\-\ there\\:\\ 0\\.005505262149199085\ \(0\)\
\-\ from\\:\\ 0\\.00548240568465027\ \(0\)\
\-\ mass\\:\\ 0\\.0051448528439288505\ \(0\)\
\-\ was\\:\\ 0\\.004278257671920722\ \(0\)\
\-\ for\\:\\ 0\\.0031563123317866456\ \(0\)\
\-\ is\\:\\ 0\\.002434159213786691\ \(0\)\
\-\ \\,\\:\\ 0\\.002343810091058765\ \(0\)\
\-\ with\\:\\ 0\\.0020260463392188697\ \(0\)\
\-\ to\\:\\ 0\\.0018487796902293778\ \(0\)\
\-\ \\.\\:\\ 0\\.0018441317453166898\ \(0\)\
\-\ in\\:\\ 0\\.001824230433507597\ \(0\)\
\-\ and\\:\\ 0\\.0015585195301490776\ \(0\)\
